Hemodynamic effects of dopamine in critically ill septic patients.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002496:Central Venous Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007022:Hypotension / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D011651:Pulmonary Artery / Q000502:physiology; D011674:Pulse / Q000187:drug effects; D012131:Respiratory Insufficiency / Q000150:complications; D018805:Sepsis / Q000150:complications; D012772:Shock, Septic / Q000652:urine; D014554:Urination / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D004071:Digitalis Glycosides; D014662:Vasoconstrictor Agents; D010100:Oxygen; D004298:Dopamine